We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
22 hedge funds and large institutions have $872K invested in Plus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
10% more funds holding
Funds holding: 20 → 22 (+2)
0.02% less ownership
Funds ownership: 0.04% → 0.02% (-0.02%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
45% less capital invested
Capital invested by funds: $1.58M → $872K (-$707K)
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$80.9K |
| 2 |
Millennium Management
New York
|
+$52.9K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$10.7K |
| 4 |
VF
Virtu Financial
New York
|
+$5.73K |
| 5 |
Two Sigma Investments
New York
|
+$4.46K |
